certainli
novel
concept
faecal
microbiota
transplant
fmt
recent
garner
renew
interest
veterinari
medicin
due
remark
success
treat
recurr
clostridium
difficil
infect
cdi
man
dearth
inform
indic
efficaci
fmt
treatment
gastrointestin
disord
hors
howev
base
evid
man
veterinari
speci
anecdot
report
hors
fmt
may
use
treatment
select
case
acut
chronic
diarrhoea
inflammatori
bowel
diseas
ibd
hors
absenc
evid
expert
opinion
offer
case
select
fmt
procedur
research
need
explor
efficaci
indic
optim
prepar
storag
deliveri
fmt
hors
microb
crucial
life
hors
hindgut
ferment
hors
larg
depend
microbi
product
volatil
shortchain
fatti
acid
energi
microbiota
also
play
import
role
develop
mammalian
immun
system
mainten
intestin
health
enhanc
intestin
epitheli
barrier
van
den
abbeel
et
al
kamada
et
al
new
sequenc
technolog
advanc
understand
complex
divers
rich
equin
intestin
faecal
microbiota
shepherd
et
al
dougal
et
al
schoster
et
al
costa
et
al
intestin
microbiota
hors
recent
describ
domin
main
phyla
particularli
firmicut
phylum
includ
vast
clostridia
class
contain
addit
small
number
pathogen
variou
genera
associ
gut
health
eg
lachnospiracea
rumincoccacea
faecalibacterium
whilst
like
core
genera
speci
conserv
among
hors
mark
differ
composit
even
class
level
among
intestin
compart
increas
divers
toward
distal
gut
costa
et
al
even
among
hors
subject
similar
diet
husbandri
practic
intestin
microbiota
show
high
degre
individu
variat
dougal
et
al
schoster
et
al
studi
hors
demonstr
alter
faecal
microbiota
even
phylum
level
diseas
state
includ
coliti
costa
et
al
post
partum
colic
wees
et
al
chronic
lamin
steelman
et
al
follow
antimicrobi
administr
healthi
hors
harlow
et
al
costa
et
al
exampl
hors
undifferenti
coliti
bacteroidet
abund
phylum
compar
firmicut
healthi
control
hors
costa
et
al
meanwhil
orallyadminist
trimethoprim
sulfadiazin
tm
healthi
hors
result
drastic
decreas
member
verrucomicrobia
phylum
costa
et
al
whilst
data
implic
alter
microbiota
caus
diseas
current
much
stronger
speci
recent
equin
studi
provid
support
concept
dysbiosi
could
import
incit
caus
variou
type
diseas
advanc
sequenc
technolog
emerg
one
potenti
import
yet
underexplor
area
studi
involv
therapeut
manipul
gastrointestin
gi
microbiota
equin
case
concept
faecal
microbiota
transplant
date
back
use
orallyadminist
faecal
suspens
remedi
food
poison
man
dongjin
dynasti
centuri
china
zhang
et
al
earliest
written
refer
fmt
transfaun
veterinari
medicin
attribut
centuri
italian
anatomist
fabriciu
aquapendent
observ
cud
taken
directli
healthi
anim
place
mouth
anim
lost
capac
rumin
would
result
restor
rumin
health
borodi
et
al
rumen
transfaun
remain
common
treatment
rang
gi
disord
cattl
depet
georg
whilst
peerreview
studi
fmt
hors
equin
practition
histori
provid
nasogastr
ng
administr
faecal
tea
healthi
hors
hors
diarrhoea
anecdot
report
success
feari
hassel
addit
multitud
commerci
overthecount
probiot
product
hors
use
clinic
prevent
treatment
varieti
gi
disord
attempt
provid
refin
approach
microbiota
replac
gener
regard
safe
efficaci
data
limit
recent
review
probiot
use
hors
highlight
need
blind
placebocontrol
efficaci
trial
investig
health
benefit
schoster
et
al
suggest
research
emphasi
place
investig
clinic
outcom
relat
administr
probiot
product
contain
bacteri
speci
abund
intestin
microbiota
healthi
hors
speci
tend
differ
found
commerci
probiot
schoster
et
al
surg
interest
research
fmt
follow
report
notabl
clinic
success
treat
recurr
cdi
man
gough
et
al
kassam
et
al
cammarota
et
al
randomisedcontrol
trial
rct
evalu
fmt
termin
prematur
procedur
prove
consider
effect
treat
recurr
cdi
antibiot
alon
van
nood
et
al
total
patient
underw
fmt
cure
patient
one
duoden
infus
donor
faec
compar
patient
receiv
standard
vancomycin
treatment
success
cure
fmt
demonstr
increas
microbiota
divers
similar
donor
follow
treatment
van
nood
et
al
although
trial
includ
small
number
patient
gener
tremend
interest
fmt
scientif
commun
popular
press
success
fmt
treat
recurr
cdi
emerg
evid
efficaci
inflammatori
gi
condit
sever
cdi
immunocompromis
patient
sever
cdi
refractori
convent
medic
therapi
zainah
et
al
ulcer
coliti
colman
rubin
util
treat
gi
nongi
disord
activ
investig
aroniadi
brandt
howev
treatment
cdi
current
approv
use
fmt
man
purpos
paper
review
current
literatur
fmt
transfaun
man
anim
propos
initi
guidelin
applic
equin
medicin
outlin
area
futur
studi
recent
evid
indic
microorgan
make
intestin
microbiota
integr
involv
host
homeostasi
alter
associ
varieti
diseas
process
man
includ
mani
previous
associ
gut
infecti
aetiolog
eg
chronic
fatigu
syndrom
autoimmun
neurolog
disord
atherosclerosi
obes
borodi
khortu
aroniadi
brandt
smit
et
al
much
attent
paid
recent
potenti
impact
microbiota
allerg
inflammatori
condit
beyond
gut
mount
evid
clearli
illustr
role
gut
microbiota
system
inflamm
immun
toler
van
den
abbeel
et
al
kamada
et
al
studi
germfre
mice
demonstr
intestin
microbiota
play
vital
role
physiolog
intestin
peristalsi
intestin
epitheli
cell
function
develop
gutassoci
immun
system
system
immun
nutrit
metabol
frick
autenrieth
gi
microbiota
produc
antimicrobi
product
compet
directli
nutrient
pathogen
inhibit
inactiv
bacteri
toxin
produc
bacteriocin
shortchain
fatti
acid
inhibit
growth
pathogen
pathobiont
kamada
et
al
microbiota
also
shown
modifi
virul
factor
express
pathogen
facilit
host
barrier
function
upregul
mucu
product
antimicrobi
molecul
secret
iga
kamada
et
al
disrupt
exist
microbi
commun
implic
pathophysiolog
cdi
may
import
factor
acut
undifferenti
antibioticinduc
coliti
hors
clostridium
difficil
normal
inhabit
larg
intestin
small
percentag
healthi
hors
man
schoster
et
al
petrof
khortu
colonis
individu
toxigen
strain
c
difficil
produc
diseas
like
inhibitori
effect
protect
commens
microbiota
howev
alter
complex
balanc
result
environ
c
difficil
prolifer
produc
toxin
caus
diseas
antimicrobi
administr
profound
prolong
impact
normal
intestin
microbiota
hors
man
jakobsson
et
al
steven
et
al
harlow
et
al
modi
et
al
costa
et
al
suggest
risk
factor
cdi
speci
b
averud
et
al
barr
et
al
petrof
khortu
high
throughput
sequenc
demonstr
tm
administ
per
os
healthi
hors
greater
effect
procain
penicillin
intramuscularli
im
ceftiofur
im
intestin
microbiota
impact
faecal
microbiota
commun
structur
persist
day
end
treatment
studi
endpoint
antibiotictr
hors
costa
et
al
risk
factor
cdi
hors
includ
stressor
transport
hospitalis
presurg
fast
medic
surgic
treatment
gi
disord
b
averud
et
al
man
similar
rang
factor
associ
increas
risk
cdi
includ
recent
focu
potenti
role
proton
pump
inhibitor
ppi
class
medic
also
commonli
use
hors
risk
factor
barletta
sclar
clostridium
difficil
caus
infect
product
toxin
destroy
intestin
epithelium
lead
sever
inflamm
secretori
diarrhoea
rupnik
et
al
convent
treatment
eg
cessat
incit
antimicrobi
use
antibiot
c
difficil
fail
fmt
may
effect
mean
restor
normal
intestin
microbiota
treat
cdi
particularli
recurr
cdi
potenti
mechan
action
fmt
includ
competit
limit
resourc
direct
elimin
c
difficil
interfer
pathogen
microbi
product
neutralis
toxin
restor
secondari
bile
acid
metabol
colon
induct
immunemedi
resist
britton
young
petrof
khortu
studi
indic
human
patient
receiv
fmt
treatment
recurr
cdi
commonli
clinic
resolut
diarrhoea
evid
faecal
microbiota
recoveri
khorut
et
al
van
nood
et
al
song
et
al
suggest
resolut
diarrhoea
relat
factor
full
restor
gut
microbiota
repres
faecal
microbiota
reason
incomplet
proxi
proxim
intestin
tract
stabl
engraft
transplant
microb
occur
may
take
time
achiev
altern
key
clinic
resolut
may
develop
overal
microbiota
akin
donor
restor
key
compon
eg
lachnospiracea
potenti
mechan
fmt
improv
outcom
gi
nongi
disord
activ
investig
determin
direct
causal
revers
condit
aroniadi
brandt
smit
et
al
khorut
weingarden
faecal
enema
use
infrequ
start
treatment
pseudomembran
enterocol
condit
thought
associ
cdi
khorut
weingarden
earliest
procedur
nonstandardis
deliv
via
enema
colonoscopi
nasoduoden
nasogastr
tube
gough
et
al
aroniadi
brandt
standardis
cryopreserv
protocol
sinc
describ
hamilton
et
al
petrof
khortu
satokari
et
al
howev
need
cryopreserv
unclear
randomis
clinic
trial
man
compar
fresh
vs
frozen
without
cryopreserv
stool
show
lack
inferior
frozen
stool
wees
unpublish
data
typic
fmt
dose
singl
donor
limit
risk
diseas
transmiss
khorut
weingarden
donor
screen
tend
intens
expens
reduc
risk
transmiss
enter
bloodborn
pathogen
infus
antigen
tabl
guidelin
strictli
evidencebas
optim
practic
unknown
allenverco
et
al
addit
research
need
explor
potenti
transfer
antimicrobi
resist
gene
plasmid
genom
donat
bacteria
dick
et
al
impress
efficaci
fmt
achiev
clinic
cure
recurr
cdi
man
systemat
review
gough
et
al
kassam
et
al
cammarota
et
al
case
seri
case
report
one
rct
patient
treat
experienc
resolut
diarrhoea
cammarota
et
al
resolut
rate
vari
site
infus
highest
caecum
ascend
colon
interestingli
report
complic
although
patient
receiv
fmt
often
debilit
elderli
immunocompromis
multipl
system
problem
disrupt
gut
mucos
barrier
khorut
weingarden
complic
report
possibl
associ
upper
gi
fmt
deliveri
includ
upper
gi
bleed
enter
periton
mortal
associ
fmt
report
studi
fmt
cdi
kassam
et
al
sever
advers
event
directli
attribut
fmt
report
studi
review
gough
et
al
cammarota
et
al
differ
clinic
outcom
anonym
vs
patient
select
donor
kassam
et
al
hand
fmt
treatment
ibd
mix
result
metaanalysi
cohort
studi
case
studi
one
rct
patient
achiev
clinic
cure
studi
microbiota
evalu
preand
post
fmt
variabl
associ
clinic
respons
colman
rubin
addit
work
need
defin
case
select
time
util
fmt
treatment
ibd
american
colleg
gastroenterolog
recommend
physician
consid
fmt
third
recurr
cdi
nonrespons
metronidazol
vancomycin
surawicz
et
al
nonprofit
stool
bank
univers
establish
donor
screen
sampl
storag
capabl
serv
physician
unabl
perform
donor
select
screen
kelli
standardis
microbiota
suspens
deriv
fresh
stool
receiv
unit
state
food
drug
administr
fda
fasttrack
statu
phase
safeti
data
show
major
advers
effect
overal
efficaci
dubberk
et
al
fmt
procedur
regul
fda
unit
state
april
fda
move
regul
fmt
unapprov
drug
requir
procedur
clinic
trial
receiv
investig
new
drug
ind
approv
anon
object
medic
commun
result
fda
adopt
interim
polici
enforc
discret
allow
clinician
perform
fmt
cdi
respons
standard
therapi
without
obtain
ind
approv
provid
adequ
inform
consent
obtain
anon
faecal
microbiota
transplant
indic
includ
ibd
irrit
bowel
syndrom
metabol
syndrom
autoimmun
autism
requir
ind
approv
transfaun
fmt
anim
current
regul
rumen
transfaun
recent
review
depet
georg
earli
investig
effect
cud
inocul
calv
reveal
rumen
contain
bacteria
protozoa
week
age
compar
noninocul
calv
whose
rumen
contain
bacteria
pounden
hibb
rumen
fluid
alfalfaf
steer
transfer
protozoafre
sheepf
alfalfa
result
establish
speci
protozoa
within
sheep
rumen
dehor
indic
protozoa
success
transfer
host
recipi
rumen
fluid
known
contain
viabl
microb
volatil
fatti
acid
bicarbon
buffer
protein
mani
yet
unidentifi
compon
depet
georg
complex
rumen
fluid
milieu
explor
via
metabolom
analysi
saleem
et
al
zhao
et
al
rumen
transfaun
remain
common
treatment
indigest
domest
rumin
improv
rumen
function
intak
milk
product
follow
surgic
correct
left
displac
abomasum
dairi
cattl
well
provid
uniqu
microorgan
capabl
degrad
plant
toxin
expos
rumin
rager
et
al
jasmin
et
al
depet
georg
rumen
transfaun
improv
health
surviv
calv
herd
experienc
bloodi
diarrhoea
death
prewean
calv
pounden
hibb
hospit
tjd
jsw
mani
year
routin
use
fresh
rumen
transfaun
treatment
larg
number
metabol
infecti
condit
cattl
exhibit
anorexia
undergon
abdomin
surgeri
recent
jing
et
al
report
system
administ
endotoxin
alter
rumen
microbiota
yet
unknown
transfaun
restor
perturb
rumen
microbiota
caus
system
endotoxin
howev
clinic
impress
transfaun
improv
appetit
outcom
cow
toxic
mastiti
support
premis
earli
studi
effect
commens
diseas
resist
broiler
chick
inocul
ingesta
adult
rooster
place
directli
chick
crop
fewer
number
salmonella
infanti
isol
fewer
carrier
anim
noninocul
control
nurmi
rantala
restrict
use
antimicrobi
product
anim
interest
altern
mean
reduc
foodborn
pathogen
piglet
fed
spent
cider
yeast
fewer
salmonella
escherichia
bacteria
faecal
sampl
control
anim
suggest
probiot
potenti
alter
gut
microbiota
reduc
pathogen
load
upadrasta
et
al
also
recent
interest
fmt
dog
cat
treatment
chronic
diarrhoea
anecdot
data
current
domin
scientif
studi
although
preliminari
studi
efficaci
murphi
et
al
neonat
foal
gut
microbiota
chang
dramat
time
foal
practic
coprophagia
dam
environ
thought
part
normal
develop
francissmith
woodgush
foal
pastur
dam
mare
foal
observ
ingest
manur
dam
mare
foal
immedi
defaec
age
week
suggest
evolutionari
adapt
effici
inocul
gi
tract
francissmith
woodgush
day
age
increas
bacteri
divers
chang
rel
abund
foal
faecal
microbiota
note
bordin
et
al
day
foal
develop
faecal
microbiota
remain
stabl
remaind
first
year
life
faubladi
et
al
chang
microbiota
time
consid
part
normal
development
process
evid
certain
diseas
process
manag
practic
medic
alter
equin
gut
microbiota
exampl
adult
hors
undifferenti
coliti
grass
sick
post
partum
colic
acut
chronic
lamin
simpl
obstruct
colic
diet
chang
supplement
note
antimicrobi
administr
also
associ
chang
equin
intestin
faecal
microbiota
garrett
et
al
will
et
al
et
al
costa
et
al
costa
et
al
dali
et
al
steelman
et
al
harlow
et
al
dougal
et
al
fernand
et
al
moreau
et
al
proudman
et
al
wees
et
al
extrapol
data
man
cattl
difficult
differ
target
diseas
gi
anatomi
hindgut
ferment
hors
intestin
tract
profoundli
differ
man
rumin
type
chronic
diseas
usual
target
fmt
speci
also
littl
relationship
import
problem
hors
due
long
small
colon
hors
fmt
via
enema
may
effect
author
knowledg
investig
faecal
microbiota
transplant
hors
thu
far
limit
administr
via
ng
intub
efficaci
rout
may
reduc
due
bacteri
inhibit
degrad
gastric
acid
small
intestin
enzymat
digest
competit
degrad
caecum
due
ferment
therefor
clear
impact
fmt
man
rumen
transfaun
provid
proof
concept
equin
specif
studi
requir
small
case
seri
hors
antibioticinduc
undifferenti
coliti
improv
faecal
consist
follow
treatment
fmt
mullen
et
al
one
author
tjd
use
fresh
caecal
transfaun
success
hors
sever
subacut
cdi
normal
manur
consist
return
h
post
treatment
chronic
diarrhoea
although
uncommon
hors
anecdot
respond
treatment
fmt
feari
hassel
mcgovern
caecal
content
collect
recent
deceas
hors
faec
obtain
rectal
evacu
healthi
hors
provid
transfaun
feari
hassel
find
provid
initi
support
potenti
efficaci
fmt
hors
howev
variabl
sometim
selflimit
natur
gi
diseas
preclud
definit
assess
efficaci
studi
equin
studi
need
develop
optim
practic
includ
transplant
materi
type
donor
characterist
donor
screen
transplant
method
diseas
target
antibioticinduc
undifferenti
coliti
ibd
associ
chang
gut
microbiota
man
aroniadi
brandt
smit
et
al
dog
minamoto
et
al
may
potenti
candid
addit
fmt
research
hors
yasuda
et
al
demonstr
differ
composit
lumin
mucos
gi
microbiota
rhesu
macaqu
preliminari
result
show
differ
composit
equin
gi
lumin
mucos
microbiota
k
yasuda
unpublish
data
diseas
ibd
may
associ
perturb
mucos
microbiota
develop
prepar
restor
mucos
microbiota
health
hors
ibd
might
help
amelior
clinic
sign
base
find
mice
intestin
microflora
promot
peristalsi
huseby
et
al
duodenitisproxim
jejun
dpj
ileu
may
disord
would
benefit
fmt
treatment
research
hors
need
studi
evalu
use
fmt
treatment
diarrhoea
foal
unlik
man
recurr
cdi
uncommon
hors
equin
cdi
case
present
sever
acut
enterocol
moreov
acut
undifferenti
coliti
common
cdi
hors
regardless
indic
administr
fmt
may
present
risk
donorassoci
bacteraemia
although
treatment
use
human
patient
compromis
mucos
barrier
function
concurr
treatment
immunosuppress
medic
without
complic
khorut
weingarden
infus
small
volum
faec
rel
amount
intestin
content
alreadi
present
would
seem
limit
addit
risk
addit
restor
normal
commens
may
actual
improv
recruit
neutrophil
gut
mucosa
protect
septic
complic
hasegawa
et
al
standard
protocol
fmt
hors
develop
preliminari
guidelin
base
limit
data
extrapol
literatur
man
expert
opinion
provid
tabl
although
advers
event
associ
fmt
hors
report
diseas
transmiss
donor
recipi
possibl
naylor
dunkel
propos
screen
test
donor
provid
tabl
foal
undergo
fmt
dam
would
make
suitabl
donor
provid
screen
criteria
met
fresh
faec
collect
rectum
screen
donor
caecal
content
could
collect
hors
fit
inclus
criteria
subject
euthanasia
acut
noninfecti
nongi
diseas
event
eg
acut
catastroph
musculoskelet
injuri
studi
compar
microbiota
caecum
faec
variabl
result
studi
suggest
signific
differ
popul
structur
two
dougal
et
al
costa
et
al
other
find
highest
similar
composit
microbiota
faec
caecum
vs
intestin
compart
schoster
et
al
howev
data
suggest
whether
caecal
content
faec
constitut
prefer
transfaun
process
deliveri
fmt
shown
fig
hospit
krm
tjd
jsw
utilis
frozen
aliquot
fmt
without
cryopreserv
howev
simpli
know
impact
storag
temperatur
time
efficaci
absenc
evid
fresh
fmt
probabl
best
discontinu
antimicrobi
fmt
well
pretreat
ppi
similar
human
protocol
recommend
diminish
antimicrobi
gastric
acidinduc
bacteri
inhibit
remain
specul
feari
hassel
follow
omeprazol
mgkg
bwt
per
os
everi
h
intragastr
ph
clinic
ill
clinic
normal
neonat
foal
healthi
adult
hors
significantli
increas
h
first
time
point
measur
respect
merritt
et
al
sanchez
et
al
fda
current
exercis
enforc
discret
fmt
permit
physician
treat
human
patient
recurr
cdi
provid
inform
consent
obtain
anon
fmt
veterinari
speci
current
regul
complic
rare
kassam
et
al
dick
et
al
patient
select
criteria
chronic
diarrhoea
antibioticinduc
coliti
acutesever
coliti
ibd
possibl
duodenitisproxim
jejun
anecdot
chronic
diarrhoea
hors
feari
hassel
minim
acutesever
antibiot
induc
coliti
hors
mullen
et
al
moder
efficaci
ibd
man
colman
rubin
studi
evalu
fmt
ibd
proxim
duodenitisproxim
jejun
hors
studi
need
recommend
treatment
six
month
withdraw
period
recommend
donor
man
hamilton
et
al
evid
forag
fed
hors
differ
microbiom
concentr
fed
hors
dougal
et
al
javsica
sanchez
suggest
short
pretreat
period
ppi
need
increas
intragastr
ph
fmt
hors
optim
volum
fmt
determin
typic
dosag
provid
tabl
research
need
determin
core
microbiota
requir
equin
gi
health
like
import
achiev
stabl
engraft
host
microbiota
recipi
establish
key
popul
eg
lachnospiracea
ruminococcacea
perhap
butyr
acet
produc
best
way
deliv
bacteria
fmt
probiot
product
stool
substitut
need
evalu
use
shelfstabl
stool
substitut
made
purifi
isol
healthi
donor
petrof
et
al
would
elimin
need
donor
screen
could
improv
access
abil
perform
control
efficaci
studi
research
need
investig
efficaci
fmtstool
substitut
treatment
specif
equin
gi
diseas
includ
acut
chronic
diarrhoea
ibd
dpj
post
foal
colic
prophylact
use
instanc
hors
undergo
surgic
procedur
hors
treat
antimicrobi
post
partum
mare
recent
develop
understand
microbiota
chang
variou
diseas
state
therapi
aim
microbiota
restor
may
repres
next
frontier
equin
gastroenterolog
conflict
interest
declar
fig
faec
obtain
rectal
evacu
caecal
content
obtain
immedi
post
mortem
healthi
donor
combin
warm
water
isoton
salin
b
use
immers
blender
cellulolyt
bacteria
releas
long
fibr
c
mixtur
pass
wire
mesh
strainer
liquid
collect
clean
plastic
bottl
fresh
administr
frozen
administr
later
frozen
prepar
thaw
warm
water
bath
administr
averages
adult
recipi
administ
l
fmt
via
nasogastr
tube
follow
l
warm
water
e
recipi
offer
long
stem
first
cut
grass
hay
inform
consent
obtain
owner
anim
use
studi
none
